Abstract
This article deals with the problem Atopic dermatitis is a chronic relapsing inflammatory skin disease with a complex pathogenesis, involving genetic predisposition, dysfunction of the immunological and epidermal barrier, as well as environmental factors.
The aim of the article is to analyze the increase in the effectiveness of atopic dermatitis (AD) therapy by correcting the protective function of natural immunoglobulins G, which play a leading role in the formation of adaptive immunity, using low molecular weight synthetic peptide preparations consisting of L- and D-amino acids. Thus, the pathogenetic concept of peptide regulation of the protective function of the B-system of immunity opens up new possibilities in the treatment and prevention of AD.